Literature DB >> 17170829

Petrous Apex Cholesteatoma: Exteriorization vs. Subtotal Petrosectomy with Obliteration.

G M Pyle, R J Wiet.   

Abstract

True cholesteatomas developing medial to the labyrinth and facial nerve with extension into the petrous apex are uncommon lesions. More recent techniques of total matrix removal and obliteration require the otoneurosurgeon to be knowledgeable of intratemporal facial nerve mobilization techniques. Total cholesteatoma matrix removal and obliteration may obviate the need for frequent care of the exteriorized cavity. However, these procedures can be associated with extensive recurrence from residual disease and close radiographic follow-up is a necessity. We review our experience with ten cases of petrous apex keratoma treated with both techniques. Six cases were managed with an exteriorization technique and four patients underwent subtotal petrosectomy with obliteration. Advantages, disadvantages, and complications of both methods are presented and guidelines for selecting a particular approach are suggested.

Entities:  

Year:  1991        PMID: 17170829      PMCID: PMC1656322          DOI: 10.1055/s-2008-1056988

Source DB:  PubMed          Journal:  Skull Base Surg        ISSN: 1052-1453


  13 in total

1.  Surgery of the skull base: transcochlear approach to the petrous apex and clivus.

Authors:  W F House; A De la Cruz; W E Hitselberger
Journal:  Otolaryngology       Date:  1978 Sep-Oct

2.  Primary cholesteatomata of the temporal bone.

Authors:  T CAWTHORNE; A GRIFFITH
Journal:  Arch Otolaryngol       Date:  1961-03

3.  Primary closure of the radical mastoidectomy wound: a technique to eliminate postoperative care.

Authors:  J H T RAMBO
Journal:  Laryngoscope       Date:  1958-07       Impact factor: 3.325

4.  Cystic lesions of the petrous apex: transsphenoid approach.

Authors:  W W Montgomery
Journal:  Ann Otol Rhinol Laryngol       Date:  1977 Jul-Aug       Impact factor: 1.547

5.  Reconstruction of the ossicular chain with an autologous bone cylinder, produced with a hollow drill. Technique and application: a preliminary report.

Authors:  R N Berkovits; C Kruithof; C E Bos; J van der Berg
Journal:  J Laryngol Otol       Date:  1978-11       Impact factor: 1.469

6.  Congenital cholesteatoma of the middle ear and mastoid.

Authors:  E L Derlacki; J D Clemis
Journal:  Ann Otol Rhinol Laryngol       Date:  1965-09       Impact factor: 1.547

7.  The investigation and management of petrous apex erosion.

Authors:  L M Flood; J L Kemink; M D Graham
Journal:  J Laryngol Otol       Date:  1985-05       Impact factor: 1.469

8.  Obliteration of the middle ear and mastoid cleft in subtotal petrosectomy: indications, technique, and results.

Authors:  N J Coker; H A Jenkins; U Fisch
Journal:  Ann Otol Rhinol Laryngol       Date:  1986 Jan-Feb       Impact factor: 1.547

9.  Cholesteatoma in the petrous apex.

Authors:  N Yanagihara; Y Matsumoto
Journal:  Laryngoscope       Date:  1981-02       Impact factor: 3.325

10.  Differential clinical and radiographic features of cholesterol granulomas and cholesteatomas of the petrous apex.

Authors:  P G Smith; J P Leonetti; G R Kletzker
Journal:  Ann Otol Rhinol Laryngol       Date:  1988 Nov-Dec       Impact factor: 1.547

View more
  3 in total

1.  Does endoscopic surgery reduce recurrence of the petrous apex cholesteatoma?

Authors:  Tolgar Lütfi Kumral; Yavuz Uyar; Güven Yıldırım; Güler Berkiten; Ayça Tazegül Mutlu; Mehmet Vefa Kılıç
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2013-03-14

2.  A giant cholesteatoma of the mastoid extending into the foramen magnum: A case report and review of literature.

Authors:  Seidu A Richard; Li Qiang; Zhi Gang Lan; Yuekang Zhang; Chao You
Journal:  Neurol Int       Date:  2018-04-04

3.  Exteriorization of Petrous Bone Cholesteatoma by Endonasal Endoscopic Approach: A Case Report.

Authors:  Naoya Nishida; Takuya Fujiwara; Suehiro Satoshi; Akira Inoue; Daiki Takagi; Taro Takagi; Naohito Hato
Journal:  J Int Adv Otol       Date:  2021-07       Impact factor: 1.017

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.